Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines

Pigment Cell and Melanoma Research

Volumn 28, Issue 4, 2015, Pages 464-475

  Lazar, Ikrame ^a,b   Clement, Emily ^a,b   Ducoux Petit, Manuelle ^a,b   Denat, Laurence ^c   Soldan, Vanessa ^d   Dauvillier, Stéphanie ^a,b   Balor, Stéphanie ^d   Burlet Schiltz, Odile ^a,b   Larue, Lionel ^c   Muller, Catherine ^a,b   Nieto, Laurence ^a,b  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c Centre National de la Recherche Scientifique   (France)

^d IBCG   (France)

Author keywords

Biomarker; Cancer; Exosome; Extracellular vesicles; Melanoma; Metastasis; Proteome

Indexed keywords

MELANOMA ANTIGEN; PROTEOME; TUMOR PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; EXOSOME; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MELANOMA; MELANOMA CELL LINE; MELANOMA METASTASIS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEOMICS; CELL MOTION; MASS SPECTROMETRY; METABOLISM; METASTASIS; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; EXOSOMES; HUMANS; MASS SPECTROMETRY; MELANOMA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROTEOME; PROTEOMICS;

EID: 84930922354     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12380     Document Type: Article

References (39)

1. Alegre, E., Sanmamed, M.F., Rodriguez, C., Carranza, O., Martin-Algarra, S., and Gonzalez, A. (2014). Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma. Arch. Pathol. Lab. Med. 138, 828-832.
2. Al-Nedawi, K., Meehan, B., Kerbel, R.S., Allison, A.C., and Rak, J. (2009). Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc. Natl Acad. Sci. USA 106, 3794-3799.
3. Atay, S., Banskota, S., Crow, J., Sethi, G., Rink, L., and Godwin, A.K. (2014). Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proc. Natl Acad. Sci. USA 111, 711-716.
4. Chen, W.X., Cai, Y.Q., Lv, M.M., Chen, L., Zhong, S.L., Ma, T.F., Zhao, J.H., and Tang, J.H. (2014). Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs. Tumour Biol. 35, 9649-9659.
5. Ciravolo, V., Huber, V., Ghedini, G.C. et al. (2012). Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J. Cell. Physiol. 227, 658-667.
6. Clayton, A., Al-Taei, S., Webber, J., Mason, M.D., and Tabi, Z. (2011). Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J. Immunol. 187, 676-683.
7. Demory Beckler, M., Higginbotham, J. N., Franklin, J. L., Ham, A. J., Halvey, P. J., Imasuen, I. E., Whitwell, C., Li, M., Liebler, D. C., and Coffey, R. J. (2013). Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol. Cell Proteomics 12, 343-355.
8. Dolo, V., D'Ascenzo, S., Violini, S., Pompucci, L., Festuccia, C., Ginestra, A., Vittorelli, M.L., Canevari, S., and Pavan, A. (1999). Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin. Exp. Metastasis 17, 131-140.
9. Ekstrom, E.J., Bergenfelz, C., von Bulow, V., Serifler, F., Carlemalm, E., Jonsson, G., Andersson, T., and Leandersson, K. (2014). WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Mol. Cancer 13, 88.
10. Federici, C., Petrucci, F., Caimi, S. et al. (2014). Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS ONE 9, e88193.
11. Felicetti, F., Parolini, I., Bottero, L. et al. (2009). Caveolin-1 tumor-promoting role in human melanoma. Int. J. Cancer 125, 1514-1522.
12. Hedlund, M., Nagaeva, O., Kargl, D., Baranov, V., and Mincheva-Nilsson, L. (2011). Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. PLoS ONE 6, e16899.
13. Hong, B.S., Cho, J.H., Kim, H. et al. (2009). Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genom. 10, 556.
14. Hood, J.L., Pan, H., Lanza, G.M., and Wickline, S.A. (2009). Paracrine induction of endothelium by tumor exosomes. Lab. Invest. 89, 1317-1328.
15. Hood, J.L., San, R.S., and Wickline, S.A. (2011). Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 71, 3792-3801.
16. Huang Da, W., Sherman, B.T., and Lempicki, R.A. (2009a). Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13.
17. Huang Da, W., Sherman, B.T., and Lempicki, R.A. (2009b). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57.
18. King, H.W., Michael, M.Z., and Gleadle, J.M. (2012). Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer 12, 421.
19. Logozzi, M., de Milito, A., Lugini, L. et al. (2009). High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE 4, e5219.
20. Mears, R., Craven, R.A., Hanrahan, S., Totty, N., Upton, C., Young, S.L., Patel, P., Selby, P.J., and Banks, R.E. (2004). Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 4, 4019-4031.
21. Miller, A.J., and Mihm, M.C. Jr (2006). Melanoma. N. Engl. J. Med. 355, 51-65.
22. Muralidharan-Chari, V., Clancy, J.W., Sedgwick, A., and D'Souza-schorey, C. (2010). Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci. 123, 1603-1611.
23. Parolini, I., Federici, C., Raggi, C. et al. (2009). Microenvironmental pH is a key factor for exosome traffic in tumor cells. J. Biol. Chem. 284, 34211-34222.
24. Peinado, H., Aleckovic, M., Lavotshkin, S. et al. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891.
25. Raposo, G., and Stoorvogel, W. (2013). Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373-383.
26. Rappa, G., Mercapide, J., Anzanello, F., Pope, R.M., and Lorico, A. (2013). Biochemical and biological characterization of exosomes containing prominin-1/CD133. Mol. Cancer 12, 62.
27. Riches, A., Campbell, E., Borger, E., and Powis, S. (2014). Regulation of exosome release from mammary epithelial and breast cancer cells - a new regulatory pathway. Eur. J. Cancer 50, 1025-1034.
28. Ridley, A.J., Schwartz, M.A., Burridge, K., Firtel, R.A., Ginsberg, M.H., Borisy, G., Parsons, J.T., and Horwitz, A.R. (2003). Cell migration: integrating signals from front to back. Science 302, 1704-1709.
29. Saito, R., Smoot, M.E., Ono, K., Ruscheinski, J., Wang, P.L., Lotia, S., Pico, A.R., Bader, G.D., and Ideker, T. (2012). A travel guide to Cytoscape plugins. Nat. Methods 9, 1069-1076.
30. Simons, M., and Raposo, G. (2009). Exosomes - vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21, 575-581.
31. Skog, J., Wurdinger, T., Van Rijn, S., Meijer, D.H., Gainche, L., Sena-Esteves, M., Curry, W.T. Jr, Carter, B.S., Krichevsky, A.M., and Breakefield, X.O. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476.
32. Taylor, D.D., and Gercel-Taylor, C. (2008). MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110, 13-21.
33. Thery, C., Ostrowski, M., and Segura, E. (2009). Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593.
34. Valenti, R., Huber, V., Filipazzi, P., Pilla, L., Sovena, G., Villa, A., Corbelli, A., Fais, S., Parmiani, G., and Rivoltini, L. (2006). Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 66, 9290-9298.
35. Valenti, R., Huber, V., Iero, M., Filipazzi, P., Parmiani, G., and Rivoltini, L. (2007). Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res. 67, 2912-2915.
36. Webber, J., Steadman, R., Mason, M.D., Tabi, Z., and Clayton, A. (2010). Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res. 70, 9621-9630.
37. Wehrle-Haller, B. (2000). The role of integrins in cell migration. In Integrins in Development, E., Danen, ed. (Georgetown, TX: Landes Bioscience), pp. 25-48.
38. Xiao, D., Ohlendorf, J., Chen, Y., Taylor, D.D., Rai, S.N., Waigel, S., Zacharias, W., Hao, H., and McMasters, K.M. (2012). Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS ONE 7, e46874.
39. Yuana, Y., Sturk, A., and Nieuwland, R. (2013). Extracellular vesicles in physiological and pathological conditions. Blood Rev. 27, 31-39.